Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus

Andrea Chiricozzi, Nicola Pimpinelli, Federica Ricceri, Giovanni Bagnoni, Laura Bartoli, Mauro Bellini, Luca Brandini, Marzia Caproni, Antonio Castelli, Michele Fimiani, Franco Marsili, Carlo Mazzatenta, Maria Chiara Niccoli, Salvatore Panduri, Michele Pellegrino, Riccardo Sirna, Walter Volpi, Marco Romanelli, Francesca Prignano

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Psoriasis is a chronic and relapsing inflammatory skin disease, clinically characterized by erythematous and scaly plaques. Treatment approach is mainly driven by disease severity, though several factors should be considered in order to identify the optimal therapeutic choice. Mild psoriasis may be treated with a wide array of topical agents including corticosteroids, vitamin D analogs, keratolytics, and calcipotriol/betamethasone propionate compound. Because guidelines may not provide practical indications regarding the therapeutic approach, the use of topical agents in psoriasis is more individually tailored. In order to homogenize the standard of care, at least in a local setting, we collected the real-life-based recommendations for the use of topical therapies from an expert panel, the Tuscany Consensus Group on Psoriasis, representing all leading centers for psoriasis established in Tuscany. With this document, this consensus group sought to define principles guiding the selection of therapeutic agents with straightforward recommendations derived from a real-life setting.
Lingua originaleEnglish
pagine (da-a)e12549-N/A
RivistaDermatologic Therapy
Volume30
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • consensus
  • psoriasis
  • therapy
  • topical

Fingerprint

Entra nei temi di ricerca di 'Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus'. Insieme formano una fingerprint unica.

Cita questo